Competitive, multi‐objective, and compartmented Flux Balance Analysis for addressing tissue‐specific inborn errors of metabolism
Journal of Inherited Metabolic Disease · 2023-07 · 46 (4) · 573-585
DOI: 10.1002/jimd.12603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 07.04.2023. Verfasst von Yanhua Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Phenylketonurias, Phenylalanine Hydroxylase. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The inborn error of metabolism phenylketonuria (PKU, OMIM 261600) is most often due to inactivation of phenylalanine hydroxylase (PAH), which converts phenylalanine (Phe) into tyrosine (Tyr). The reduced PAH activity increases blood concentration of phenylalanine and urine levels of phenylpyruvate. Flux balance analysis (FBA) of a single‐compartment model of PKU predicts that maximum growth rate should be reduced unless Tyr is supplemented. However, the PKU phenotype is lack of development of brain function specifically, and Phe reduction rather than Tyr supplementation cures the disease. Phe and Tyr cross the blood–brain barrier (BBB) through the aromatic amino acid transporter implying that the two transport reactions interact. However, FBA does not accommodate such competitive interactions. We here report on an extension to FBA that enables it to deal with such interactions. We built a three‐compartment model, made the common transport across the BBB explicit, and included dopamine and serotonin synthesis as parts of the brain function to be delivered by FBA. With these ramifications, FBA of the genome‐scale metabolic model extended to three compartments does explain that (i) the disease is brain specific, (ii) phenylpyruvate in urine is a biomarker, (iii) excess of blood‐phenylalanine rather than shortage of blood‐tyrosine causes brain pathology, and (iv) Phe deprivation is the better therapy. The new approach also suggests (v) explanations for differences in pathology between individuals with the same PAH inactivation, and (vi) interference of disease and therapy with the functioning of other neurotransmitters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands.
- Molecular Cell Biology, Amsterdam Institute for Molecules, Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
ORCID-Profile: Yanhua Liu, Hans V Westerhoff
Zitieren
APA
Liu, Y., & Westerhoff, H. V. (2023). Competitive, multi‐objective, and compartmented Flux Balance Analysis for addressing tissue‐specific inborn errors of metabolism. Journal of Inherited Metabolic Disease, 46(4), 573-585. https://doi.org/10.1002/jimd.12603
Vancouver
Liu Y, Westerhoff HV. Competitive, multi‐objective, and compartmented Flux Balance Analysis for addressing tissue‐specific inborn errors of metabolism. Journal of Inherited Metabolic Disease. 2023;46(4):573-585. doi:10.1002/jimd.12603
BibTeX
@article{Liu2023,
author = {Liu, Yanhua and Westerhoff, Hans V},
title = {Competitive, multi‐objective, and compartmented Flux Balance Analysis for addressing tissue‐specific inborn errors of metabolism},
journal = {Journal of Inherited Metabolic Disease},
year = {2023},
volume = {46},
number = {4},
pages = {573--585},
doi = {10.1002/jimd.12603}
}
EUVIMED